Report Detail
Global (United States, European Union and China) Drug Device Combination Products Market Research Report 2019-2025
- RnM3623156 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Drug devices facilitate early diagnosis and reduced treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.
The global drug device combination product market size is expected to reach USD 176 billion by 2024. Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.
Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.
In 2019, the market size of Drug Device Combination Products is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug Device Combination Products.
This report studies the global market size of Drug Device Combination Products, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug Device Combination Products production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
Terumo Corporation
Stryker Corporation
Mylan N.V.
Medtronic
St.Jude Medical, Inc.
Allergan, Plc
Boston Scientific Corporation
Novartis AG
Teleflex Incorporated
C.R. Bard, Inc.
W.L.Core & Associates, Inc.
Market Segment by Product Type
Drug-eluting stents
Prefilled syringes
Wearable injectors
Insulin injector drug
Market Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug Device Combination Products status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug Device Combination Products manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drug Device Combination Products are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Drug Device Combination Products Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Drug-eluting stents
- 1.3.3 Prefilled syringes
- 1.3.4 Wearable injectors
- 1.3.5 Insulin injector drug
- 1.4 Market Segment by Application
- 1.4.1 Global Drug Device Combination Products Market Share by Application (2019-2025)
- 1.4.2 Hospitals and Clinics
- 1.4.3 Medical Laboratories
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Drug Device Combination Products Production Value 2014-2025
- 2.1.2 Global Drug Device Combination Products Production 2014-2025
- 2.1.3 Global Drug Device Combination Products Capacity 2014-2025
- 2.1.4 Global Drug Device Combination Products Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Drug Device Combination Products Market Size CAGR of Key Regions
- 2.2.2 Global Drug Device Combination Products Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Drug Device Combination Products Capacity by Manufacturers
- 3.1.2 Global Drug Device Combination Products Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Drug Device Combination Products Revenue by Manufacturers (2014-2019)
- 3.2.2 Drug Device Combination Products Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Drug Device Combination Products Market Concentration Ratio (CR5 and HHI)
- 3.3 Drug Device Combination Products Price by Manufacturers
- 3.4 Key Manufacturers Drug Device Combination Products Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Drug Device Combination Products Market
- 3.6 Key Manufacturers Drug Device Combination Products Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Drug-eluting stents Production and Production Value (2014-2019)
- 4.1.2 Prefilled syringes Production and Production Value (2014-2019)
- 4.1.3 Wearable injectors Production and Production Value (2014-2019)
- 4.1.4 Insulin injector drug Production and Production Value (2014-2019)
- 4.2 Global Drug Device Combination Products Production Market Share by Type
- 4.3 Global Drug Device Combination Products Production Value Market Share by Type
- 4.4 Drug Device Combination Products Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Drug Device Combination Products Consumption by Application
6 Production by Regions
- 6.1 Global Drug Device Combination Products Production (History Data) by Regions 2014-2019
- 6.2 Global Drug Device Combination Products Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Drug Device Combination Products Production Growth Rate 2014-2019
- 6.3.2 United States Drug Device Combination Products Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Drug Device Combination Products Import & Export
- 6.4 European Union
- 6.4.1 European Union Drug Device Combination Products Production Growth Rate 2014-2019
- 6.4.2 European Union Drug Device Combination Products Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Drug Device Combination Products Import & Export
- 6.5 China
- 6.5.1 China Drug Device Combination Products Production Growth Rate 2014-2019
- 6.5.2 China Drug Device Combination Products Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Drug Device Combination Products Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Drug Device Combination Products Consumption by Regions
- 7.1 Global Drug Device Combination Products Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Drug Device Combination Products Consumption by Type
- 7.2.2 United States Drug Device Combination Products Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Drug Device Combination Products Consumption by Type
- 7.3.2 European Union Drug Device Combination Products Consumption by Application
- 7.4 China
- 7.4.1 China Drug Device Combination Products Consumption by Type
- 7.4.2 China Drug Device Combination Products Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Drug Device Combination Products Consumption by Type
- 7.5.2 Rest of World Drug Device Combination Products Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Drug Device Combination Products
- 8.1.4 Drug Device Combination Products Product Introduction
- 8.1.5 Abbott Laboratories Recent Development
- 8.2 Terumo Corporation
- 8.2.1 Terumo Corporation Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Drug Device Combination Products
- 8.2.4 Drug Device Combination Products Product Introduction
- 8.2.5 Terumo Corporation Recent Development
- 8.3 Stryker Corporation
- 8.3.1 Stryker Corporation Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Drug Device Combination Products
- 8.3.4 Drug Device Combination Products Product Introduction
- 8.3.5 Stryker Corporation Recent Development
- 8.4 Mylan N.V.
- 8.4.1 Mylan N.V. Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Drug Device Combination Products
- 8.4.4 Drug Device Combination Products Product Introduction
- 8.4.5 Mylan N.V. Recent Development
- 8.5 Medtronic
- 8.5.1 Medtronic Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Drug Device Combination Products
- 8.5.4 Drug Device Combination Products Product Introduction
- 8.5.5 Medtronic Recent Development
- 8.6 St.Jude Medical, Inc.
- 8.6.1 St.Jude Medical, Inc. Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Drug Device Combination Products
- 8.6.4 Drug Device Combination Products Product Introduction
- 8.6.5 St.Jude Medical, Inc. Recent Development
- 8.7 Allergan, Plc
- 8.7.1 Allergan, Plc Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Drug Device Combination Products
- 8.7.4 Drug Device Combination Products Product Introduction
- 8.7.5 Allergan, Plc Recent Development
- 8.8 Boston Scientific Corporation
- 8.8.1 Boston Scientific Corporation Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Drug Device Combination Products
- 8.8.4 Drug Device Combination Products Product Introduction
- 8.8.5 Boston Scientific Corporation Recent Development
- 8.9 Novartis AG
- 8.9.1 Novartis AG Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Drug Device Combination Products
- 8.9.4 Drug Device Combination Products Product Introduction
- 8.9.5 Novartis AG Recent Development
- 8.10 Teleflex Incorporated
- 8.10.1 Teleflex Incorporated Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Drug Device Combination Products
- 8.10.4 Drug Device Combination Products Product Introduction
- 8.10.5 Teleflex Incorporated Recent Development
- 8.11 C.R. Bard, Inc.
- 8.12 W.L.Core & Associates, Inc.
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Drug Device Combination Products Capacity, Production Forecast 2019-2025
- 9.1.2 Global Drug Device Combination Products Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Drug Device Combination Products Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Drug Device Combination Products Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Drug Device Combination Products Production Forecast by Type
- 9.7.2 Global Drug Device Combination Products Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Drug Device Combination Products Sales Channels
- 10.2.2 Drug Device Combination Products Distributors
- 10.3 Drug Device Combination Products Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Drug Device Combination Products. Industry analysis & Market Report on Drug Device Combination Products is a syndicated market report, published as Global (United States, European Union and China) Drug Device Combination Products Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Drug Device Combination Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
